GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » ROC (Joel Greenblatt) %

Eurofins Scientific SE (Eurofins Scientific SE) ROC (Joel Greenblatt) %

: 24.41% (As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Eurofins Scientific SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 24.41%.

The historical rank and industry rank for Eurofins Scientific SE's ROC (Joel Greenblatt) % or its related term are showing as below:

ERFSF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.76   Med: 47.6   Max: 67.65
Current: 24.85

During the past 13 years, Eurofins Scientific SE's highest ROC (Joel Greenblatt) % was 67.65%. The lowest was 24.76%. And the median was 47.60%.

ERFSF's ROC (Joel Greenblatt) % is ranked better than
78.3% of 235 companies
in the Medical Diagnostics & Research industry
Industry Median: -15.21 vs ERFSF: 24.85

Eurofins Scientific SE's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -2.70% per year.


Eurofins Scientific SE ROC (Joel Greenblatt) % Historical Data

The historical data trend for Eurofins Scientific SE's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.00 52.67 65.33 42.99 25.11

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.10 50.46 37.65 25.77 24.41

Competitive Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE ROC (Joel Greenblatt) % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's ROC (Joel Greenblatt) % falls into.



Eurofins Scientific SE ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1115.06 + 162.839 + 424.594) - (761.43 + 0 + 1032.937)
=-91.874

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1169.902 + 151.581 + 226.282) - (1424.646 + 0 + 233.696)
=-110.577

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Eurofins Scientific SE for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=597.6/( ( (2391.224 + max(-91.874, 0)) + (2505.344 + max(-110.577, 0)) )/ 2 )
=597.6/( ( 2391.224 + 2505.344 )/ 2 )
=597.6/2448.284
=24.41 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE  (OTCPK:ERFSF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Eurofins Scientific SE ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.